Oxford Cancer Biomarkers Expands Clinical Utility of ToxNav®
Oxford Cancer Biomarkers announced a Licence of Technology agreement with Oxford University Innovation to extend the clinical application of its ToxNav® test for chemotherapy toxicity risk.
Source: Plutus / Oxford Cancer Biomarkers